Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
about
TIMELESS contributes to the progression of breast cancer through activation of MYC.Manic fringe promotes a claudin-low breast cancer phenotype through notch-mediated PIK3CG induction.Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4.Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ERα-ΔNp63-Integrin β4 Signaling Pathway.Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation.Oncogenic role of the Notch pathway in primary liver cancer.3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathwayBreast cancer stem cells: are we ready to go from bench to bedside?The interplay between microRNAs and Twist1 transcription factor: a systematic review.Identification of novel 2-(1H-indol-1-yl)-benzohydrazides CXCR4 ligands impairing breast cancer growth and motility.Cancer cells remodel themselves and vasculature to overcome the endothelial barrier.Lunatic Fringe and p53 Cooperatively Suppress Mesenchymal Stem-Like Breast Cancer.Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles.The NOTCH4-HEY1 pathway induces epithelial mesenchymal transition in head and neck squamous cell carcinoma.Oval Cells Contribute to Fibrogenesis of Marginal Liver Grafts under Stepwise Regulation of Aldose Reductase and Notch Signaling.Luminal lncRNAs Regulation by ERα-Controlled Enhancers in a Ligand-Independent Manner in Breast Cancer Cells.HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a γ-secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzalutami
P2860
Q33629724-C62731C9-506D-40C1-920D-B6741D4A564CQ35612277-A3D9FF29-6882-42B0-8347-C1B2255A0FC5Q35709636-E21F4666-2606-45BB-A46D-34870EAFB13DQ35914389-F408C153-86B8-47B6-99B6-C7D43B6FC9D2Q36123897-DBE1F4DE-624A-4100-98DD-05B12C298315Q36355992-F63FAF94-7E1F-4B2E-8956-71E60BE928B1Q37001697-B9CD0253-AF4F-473A-856F-994ADF610F50Q37039887-A9076A76-B3F8-4296-ACE5-A25E4E515D56Q38696803-7A582F50-E809-4517-9F6C-66CEF0028263Q38735082-59123540-1272-454B-8274-309CF04F6728Q38799672-4B71A6CE-243D-4A45-B0D6-B5C0347A0129Q41636608-62DF6BEA-FA0D-4458-9465-AC40F25FA904Q41667225-2835DD2A-A1EA-4C5C-BBB8-3D1BDD7925F9Q46509951-9C6DA5A1-B998-4781-B577-46BD9D8DEC98Q46836705-4EC139FB-694B-4D53-B2D5-02A4A4B6A605Q47099031-AA3A0252-C431-4A54-9F1C-D2FD147DB4ADQ49805024-DD7AE1D4-695C-44EB-B0D0-E0EB91A54CDFQ55004240-C0796EF0-0BBF-46BD-8C2E-763AAA3BC546
P2860
Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Nicastrin and Notch4 drive end ...... n in MCF7 breast cancer cells.
@ast
Nicastrin and Notch4 drive end ...... n in MCF7 breast cancer cells.
@en
type
label
Nicastrin and Notch4 drive end ...... n in MCF7 breast cancer cells.
@ast
Nicastrin and Notch4 drive end ...... n in MCF7 breast cancer cells.
@en
prefLabel
Nicastrin and Notch4 drive end ...... n in MCF7 breast cancer cells.
@ast
Nicastrin and Notch4 drive end ...... n in MCF7 breast cancer cells.
@en
P2093
P2860
P356
P1476
Nicastrin and Notch4 drive end ...... on in MCF7 breast cancer cells
@en
P2093
Aleksandra Filipovic
Monica Faronato
R Charles Coombes
Valentina Vircillo
Ylenia Lombardo
P2860
P2888
P356
10.1186/BCR3675
P50
P577
2014-06-11T00:00:00Z
P5875
P6179
1012099566